Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (121-130 of 519) with videos related to

Pageof 52
Sort By:
British Journal of Haematology|October 19, 2007
Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemiaOla Landgren, Gloria Gridley, David Check, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemiaMary L McMaster, Sigurdur Y Kristinsson, Ingemar Turesson, et al.
British Journal of Haematology|March 7, 2012
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumourTamar Tadmor, Irena Liphshitz, Ariel Aviv, et al.
Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.
Haematologica|April 19, 2012
Thrombosis is associated with inferior survival in multiple myelomaSigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.
Leukemia & Lymphoma|June 5, 2014
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphomaHuei-Ting Tsai, Ruth M Pfeiffer, Joan Warren, et al.
JAMA Oncology|December 13, 2019
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A ReviewFrancesco Maura, Niccolò Bolli, Even H Rustad, et al.
Annals of Internal Medicine|August 22, 2018
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative NeoplasmsMalin Hultcrantz, Magnus Björkholm, Ola Landgren, et al.
Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Pageof 52

Showing results (121-130 of 519) with videos related to

Sort By:
Pageof 52
British Journal of Haematology|October 19, 2007
Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemiaOla Landgren, Gloria Gridley, David Check, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemiaMary L McMaster, Sigurdur Y Kristinsson, Ingemar Turesson, et al.
British Journal of Haematology|March 7, 2012
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumourTamar Tadmor, Irena Liphshitz, Ariel Aviv, et al.
Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.
Haematologica|April 19, 2012
Thrombosis is associated with inferior survival in multiple myelomaSigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.
Leukemia & Lymphoma|June 5, 2014
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphomaHuei-Ting Tsai, Ruth M Pfeiffer, Joan Warren, et al.
JAMA Oncology|December 13, 2019
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A ReviewFrancesco Maura, Niccolò Bolli, Even H Rustad, et al.
Annals of Internal Medicine|August 22, 2018
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative NeoplasmsMalin Hultcrantz, Magnus Björkholm, Ola Landgren, et al.
Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Pageof 52